VYNE
VYNE Therapeutics Inc. Common Stock
$0.60
0.00%
0.00
Notify me if price changes either direction
Buy VYNE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
19.8M
Enterprise value
-13045655
Trailing PE
0.70820665
Forward PE
-0.54072726
PEG Ratio
-0.017114994041667
Enterprise to EBITDA
0.29898597391882
Enterprise to revenue
-24.896
Price to book MRQ
0.5889109
Price to sales TTM
37.7839
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
524.0K
Diluted EPS TTM
-0.79
Total Cash (MRQ)
32.7M
Current ratio (MRQ)
8.874
Operating Cash Flow (TTM)
-38359000
VYNE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
